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Nicholas Webster3 and Arwa Kurabi1
1 Departments of Surgery/Otolaryngology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA,
United States, 2 Medicine/Center for Computational Biology & Bioinformatics, UC San Diego School of Medicine, VA Medical
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Single-cell transcriptomics was used to profile cells of the normal murine middle ear.
Clustering analysis of 6770 transcriptomes identified 17 cell clusters corresponding
to distinct cell types: five epithelial, three stromal, three lymphocyte, two monocyte,
two endothelial, one pericyte and one melanocyte cluster. Within some clusters,
cell subtypes were identified. While many corresponded to those cell types known
from prior studies, several novel types or subtypes were noted. The results indicate
unexpected cellular diversity within the resting middle ear mucosa. The resolution of
uncomplicated, acute, otitis media is too rapid for cognate immunity to play a major
role. Thus innate immunity is likely responsible for normal recovery from middle ear
infection. The need for rapid response to pathogens suggests that innate immune
genes may be constitutively expressed by middle ear cells. We therefore assessed
expression of innate immune genes across all cell types, to evaluate potential for
rapid responses to middle ear infection. Resident monocytes/macrophages expressed
the most such genes, including pathogen receptors, cytokines, chemokines and
chemokine receptors. Other cell types displayed distinct innate immune gene profiles.
Epithelial cells preferentially expressed pathogen receptors, bactericidal peptides
and mucins. Stromal and endothelial cells expressed pathogen receptors. Pericytes
expressed pro-inflammatory cytokines. Lymphocytes expressed chemokine receptors
and antimicrobials. The results suggest that tissue monocytes, including macrophages,
are the master regulators of the immediate middle ear response to infection, but that
virtually all cell types act in concert to mount a defense against pathogens.
Keywords: single-cell, middle ear, otitis media, cluster-profiling, homeostasis
INTRODUCTION
The middle ear (ME) is a bone-encased, air-filled cavity that links the external ear to the inner
ear. Bounded externally by the tympanic membrane, it houses the three ossicles that transmit
acoustic vibrations from the eardrum to the cochlea. It is connected to the nasopharynx by the
Frontiers in Genetics | www.frontiersin.org 1 April 2020 | Volume 11 | Article 358
fgene-11-00358 April 9, 2020 Time: 15:55 # 2
Ryan et al. Middle Ear Single Cell Transcriptomes
Eustachian tube, which provides intermittent ventilation and
pressure release, as well as clearance via ciliary activity.
The ME is a frequent site of infection, especially in children.
More than 90% of children experience otitis media (OM), which
is chronic-recurrent in 15−20% (Rosenfeld and Bluestone, 2003).
It is the most common cause of physician visits and surgery
at ages less than 5 years (Cullen et al., 2009). OM leads to
hearing loss during a critical period of language acquisition and
learning, and has been associated with deficits in both language
and learning (Friel-Patti et al., 1982; Wendler-Shaw et al., 1993).
OM can be well-controlled by therapy, but the annual cost in
the United States is estimated at >$5 billion (Ahmed et al.,
2014). In contrast, OM is a very serious disease in developing
countries due to limited access to medical care. Under-treated
suppurative OM is estimated by the World Health Organization
to be responsible for 28,000 annual deaths due to intracranial
infection and to cause half of the world’s burden of severe
hearing loss, approximately 240 million cases (Arguedas et al.,
2010). The resolution of uncomplicated, acute OM occurs in
less than one week, even without antibiotic treatment. This is
too rapid for the de novo elaboration of cognate immunity,
suggesting that OM is normally resolved by innate immunity.
Indeed, deficiencies in innate immune genes have been linked to
OM susceptibility in both mice and humans (Leichtle et al., 2011;
Rye et al., 2011).
The ME is an atypical mucosal site, characterized by a
largely rudimentary cellular structure, yet with the capability
to rapidly transform into a respiratory-type epithelium. The
majority of the resting ME cavity is lined by a monolayer
of simple squamous epithelial cell overlying a sparse stroma
and vasculature. However, upon infection and inflammation,
hyperplasia can produce a 20-fold increase in thickness, into a
pseudostratified, columnar epithelium populated with ciliated,
goblet and secretory cells, within a few days. Upon the resolution
of infection, the mucosa returns to its baseline structure
(Lim, 1979).
The cells that make up the normal ME mucosa have been
studied primarily morphologically. Early studies were limited
to the observation of a simple squamous lining epithelium
with ciliated cells in some areas, especially near the orifice
of the Eustachian tube (e.g., Kolmer and Mellendorff, 1927;
Wolff, 1943). Later investigations noted morphological details
that confirmed a simple squamous epithelial structure with
minimal stroma throughout much of the ME, but with some
areas of cuboidal, columnar and pseudostratified epithelium,
primarily near the Eustachian tube but also in recesses
and corners of the ME (e.g., Hentzer, 1970). Blood vessels,
lymphatics, and small numbers of immunocytes including
macrophages, lymphocytes and plasma cells were also noted
in the stroma, as were melanocytes (Lin and Zak, 1982). In
addition, histochemistry was used to demonstrate the presence
of mucopolysaccharides within both ciliated and non-ciliated
epithelial cells (e.g., Sade, 1966).
The introduction of electron microscopy to ME studies
added significant details regarding ME cell types. Based on
their ultrastructure, Lim and Hussl (1969) classified ME
epithelial cells as non-ciliated without secretory granules,
mucus-secreting goblet cells with abundant secretory
granules, intermediary secretory cells with fewer secretory
granules, ciliated cells, and subsurface basal cells. Hentzer
(1976) added a sixth class that he termed intermediate
cells, which he proposed could differentiate into any of
the other surface cell types, with intermediary secretory
cells a transitional stage into goblet cells. Ultrastructural
studies also noted pericytes in association with the endothelial
cells of vessels.
Additional information has been added by
immunohistochemistry. Takahashi et al. (1989) identified
macrophages, T-cells and B-cells in the subepithelial stroma
of the normal ME. However, these cells were sparse, with on
average less than one B cell in a histological section through
the entire ME, and 1−5 macrophages and T-cells per section.
They thus comprised a very small fraction of the cells present
in the normal ME, as observed morphologically by Lim (1979).
Immunohistochemistry was also used to document the presence
of melanocytes (Lin and Zak, 1982), pericytes (Zhang et al.,
2015), natural killer cells (Jecker et al., 1996), and mast cells
(Stenfors et al., 1985).
More recently, a lineage study found that the ME mucosal
epithelium in mice has two distinct embryonic origins. Epithelial
cells in approximately half of the ME cavity closest to the
Eustachian tube orifice originate from the endoderm of the
branchial arches, while the remainder originates from the neural
crest. In the normal ME, ciliated and goblet cells were observed
only in cells of endodermal origin, although many non-ciliated,
non-secretory cells were also present (Thompson and Tucker,
2013). More recently, ciliated cells have been documented in
the region of neural crest origin (Luo et al., 2017). However,
the dual origin of cells adds yet another layer of complexity
to ME cell types.
Recent studies have also evaluated the transcriptome of the
normal ME mucosa (MacArthur et al., 2013; Hernandez et al.,
2015). These studies, which utilized bulk RNA, identified genes
expressed in the normal ME. However, they could not address
the genes expressed individually by the different ME cell types.
Cell-specific patterns of genes expression would help to define
the functions of various cell types and their ability to respond
to ME infection.
The purpose of the present study was to document the
expression of genes in individual ME cells. We sought to identify
the cell types present in the ME cavity at a single-cell resolution,
to illuminate their functional characteristics, and to evaluate the
cellular distribution of genes known to be important for the
pathogenesis and resolution of OM.
MATERIALS AND METHODS
Animals
Young adult (60−90 day old) wildtype C57Bl/6J mice (Charles
River, Wilmington, MA, United States) were used. All procedures
were performed to National Institutes of Health guidelines and
approved by the Institutional Animal Care and Use Committee
of the VA San Diego Medical Center.
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Preparation of Cell Suspensions
Groups of six mice were deeply anesthetized (ketamine 50 mg/kg,
xylazine 1 mg/kg, acepromazine 5 mg/kg in 50 µl, i.p.) and
sacrificed by decapitation, avoiding significant pressure on the
neck to prevent the rupture of blood vessels in the ME. Six
animals were required to generate a sufficient number of cells
for a 10X Genomics run, because a ME tissue sample from a
single animal are small. The ME bullae were isolated and opened
along the suture that divides the lateral from the medial ME.
ME mucosal tissue was gently harvested from the bullar bone.
Care was taken not to include any tissue from the ME muscles.
The pooled tissue was incubated with 0.5 mg/ml thermolysin
(Sigma-Aldrich, #T7902) in Leibovitz’s buffer for 25–30 min in
a 37◦C/5% CO2 humidified tissue culture incubator to dissociate
the extracellular matrix. The thermolysin was then aspirated,
the tissue rinsed, and the sample incubated in FACSMax cell
dissociation solution (Genlantis, #T200100). The cell mixture
was triturated with a pipette and further dissociated into single
cells mechanically by passing through a 23 G blunt-ended
needle. Dissociated cells were passed through a 40 µm cell
strainer (BD Biosciences) to eliminate clumps before sorting and
collected into a FACS tube on ice containing PBS buffer with
0.04% BSA. Cell viability was assessed by Trypan blue exclusion
staining and cells counted with a hemocytometer (Countess II,
Thermo Fisher Scientific). Cell viability was greater than 95%.
Following counting, the samples were diluted to 700 cells/µL.
Three replicates were performed since the typical yield of a 10X
genomics run is about 2,000 cells, and we wanted to evaluate a
higher number, plus we wanted independent biological samples
to assess replicability of the data.
Single-Cell Library Preparation
and Sequencing
Libraries were prepared using the Chromium Controller (10X
Genomics, Pleasanton, CA, United States) in conjunction with
the Single Cell 3’ Reagent Kit v2 kit user guide. Briefly, the cell
suspensions were diluted with nuclease-free water according to
manufacturer instructions to achieve an estimated cell count of
1,950 to 2,858 per sample. cDNA synthesis, barcoding, and library
preparation were then carried out in the Chromium controller
according to the manufacturers’ instructions. The libraries were
sequenced on an Illumina HiSeq 2500 (Illumina, San Diego,
United States) with a read length of 26 bp for read 1 [cell
barcode and unique molecule identifier (UMI)], 8 bp i7 index
read (sample barcode), and 98 bp for read 2 (actual RNA read).
Reads were first sequenced in the rapid run mode, allowing for
fine-tuning of sample ratios in the following high-output run.
Combining the data from both flow cells yielded approximately
200 million reads per sample.
Single-Cell Data Analysis
Reads were demultiplexed using Cellranger 2.0.2 (10X Genomics)
and mkfastq in conjunction with bcl2fastq 2.17.1.14 (Illumina).
The reads were subsequently aligned to the murine reference
genome (mm10 with annotations from Ensembl release 84),
filtered, and quantified using the Cellranger count command.
Cellranger aggr (10X Genomics) was further used to generate
an initial secondary analysis (t-distributed stochastic neighbor
embedding; t-SNE), principal component analysis (PCA)
clustering. Graph-based, as well as K-means (K = 2–10) analysis
of gene expression was used to identify the 50 most differentially
regulated genes that distinguished each PCA cell cluster.
Cellranger aggr was used to merge the count matrices from 3
independent samples.
Additional clustering analysis was conducted using R package
Seurat (Satija et al., 2015) to merge the data from the three
independent samples and generate overall cell clusters. Cells were
filtered based on quality control measurements recommended by
the Seurat developers. Genes that were expressed in less than 0.1%
of cells and cells that expressed less than 750 unique genes were
excluded from the analysis. Cells that expressed greater than 7.5%
mitochondrial genes were also excluded, as they represent dead or
injured cells. After filtering, 6,370 of 6,770 cells remained.
After quality filtering, counts were log normalized. The
FindVariableGenes function in Seurat was used to identify 2,207
highly variable genes that were used for downstream analysis.
Finally, the data were scaled and subject to PCA to reduce the
dimensionality of the dataset.
We used overrepresentation enrichment analysis (ORA)
from R package WebGestaltR. Searched geneontology biological
process database. Looked for enrichment in significantly
differentially expressed genes (adjusted p-value < 0.05) for each
cluster versus all highly variable genes (n = 2,207).
Identification of Cell Types
Cells were identified by assessing gene expression in the clusters
of the three independent samples. Two methods were used to
evaluate each of the samples. In the first, the expression of
well-recognized cell marker genes was mapped to the graph-
based clusters. For a second means of identification, the top
50 differentially expressed genes in each cluster were evaluated
for their known expression by different cell types using the
GeneCards database and the literature. From both methods,
exclusively expressed genes (defined as being expressed by>50%
of the cells in a cluster at high levels versus <2.5% of the cells
of all other clusters at low levels) that were associated with an
individual cell type were then assessed for their known cellular
expression in the literature and in the GeneCards database.
Immunohistochemistry
Expression of select genes used for cell identification was
verified by immunohistochemistry. Paraffin sections of MEs
were deparaffinized, and antigen retrieval performed with citrate
buffer, pH 6.0. The sections were exposed to primary antibodies
to: EPCAM (Sino Biological), DYNLRB2 (Thermo Fisher
Scientific), COL1A2 (LSBio), LRG (Proteintech), CSFR1 (LSBio)
and PTPRCAP (Antibodies.online), DEFB1 (BiossUSA), AREG
(LSBio), ECRG4 (Biorbyt), followed by secondary antibodies
labeled with Alexa 488 (Abcam).
Expression of Innate Immune Genes
Acute OM in most children resolves in less than a week even
in the absence of antibiotic treatment (Little et al., 2001), a
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TABLE 1 | Single cell metrics.
Sample Reads Total cells Genes/cell Reads/cell Total genes UMIs/cell
1 54.0 M 2,858 1,637 18,886 17,719 3,933
2 45.0 M 1,962 1,490 20,920 17,110 3,744
3 41.9 M 1,950 1,600 21,468 17,138 4,005
Metrics for the three independent samples of ME mucosa, each representing six mouse MEs.
FIGURE 1 | PCA clusters of cells from a sample of six normal mouse ME mucosae, generated by 10X Genomics Cellranger. Eleven separate clusters (1–11) were
produced. Marker genes were used to identify the cells of each cluster.
period too short for the full engagement of cognate immunity.
This implicates innate immunity in the normal resolution of ME
infection. In order to assess the capacity of resting ME cells to
rapidly engage innate immunity, we assessed the expression levels
of innate immune genes in our single-cell transcriptomes. For this
analysis we used the Mouse Genome Informatics gene ontology
(GO) list of 1599 innate immune transcripts representing 809
individual genes: GO:0045087.
RESULTS
Single-Cell Metrics
The mean number of transcriptomes per sample was 2,257,
typical for a single-cell sample on the 10X genomics device, for
a total of 6,770 cells. As noted above, quality control eliminating
cells with a high proportion of mitochondrial genes likely to be
dead or dying cells as well as outliers, left a total of 6,370 cells.
A mean of 45.6 million reads/sample resulted in the detection
of 17,322 genes for each tissue sample, with an average 20,425
reads/cell, 3,894 UMIs/cell and 1,576 genes/cell. The quality
control metrics for each sample are presented in Table 1.
Generation of Cell Clusters
Clustering of ME cell transcriptomes using the 10X Cellranger
pipeline resulted in a similar pattern of cell groupings for each
of the samples, identifying 11 (Figure 1), 8 and 7 clusters in the
three separate samples. Some of these clusters were subdivisions
of spatially contiguous cell groups, and generally it was variation
in the number of these subgroups that produced differences
in cluster number between samples. However, later analysis
confirmed that marker genes present in the sample with the most
clusters (11) also distinguished cell groups in the two samples
with fewer clusters, even though they had not been separated
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FIGURE 2 | (A) PCA clusters generated from the cells of all three mucosal samples, generated with Seurat. Seventeen clusters (0–16) were identified. Marker genes
were again used to determine the cells types present in each cluster. Some cell types that were grouped in contiguous clusters by Cellranger were separated in the
Seurat analysis. Marker gene expression in: (B) Epithelial cell clusters (0, 1, 2, 6, 11); (C) Stromal cell clusters (3, 4, 5); (D) Vascular cell clusters (7, 12, 13);
(E) Monocyte clusters (8, 9); and (F) Lymphocyte clusters (10, 14, 15).
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by PCA. To increase the depth of analysis, cell sequences from
the three samples were merged and analyzed using Seurat. Seurat
t-SNE clustering of the merged samples yielded 17 cell clusters,
which are illustrated in Figure 2A. Several clusters consisted of
discrete groups of cells. Others were parts of multi-cluster cell
groupings, as observed in the Cellranger analysis.
Identification of ME Cell Types
As noted above, the expression of cell type marker genes that are
well recognized in the literature was used to identify ME cell types
(Figure 2). Evaluation of cluster-specific genes (expressed by the
majority of cells in a single cluster and very few cells from other
clusters) was also used to confirm ME cell type identity, when the
literature or the GeneCards database indicated that expression
was limited to a single cell type. Genes used to identify ME cell
types are presented in Table 2.
Epithelial Cells
The largest number of cells (51.5% of all cells in the merged
samples) showed expression of genes typical of epithelia (Hackett
et al., 2011), including the epithelial cell adhesion gene Epcam
(Figure 2B), the cytokeratin genes Krt18 and Krt19, several
claudin genes, and Muc16. This included the cells of Seurat
Clusters 0, 1, 2, 6, and 11. Two of these clusters were readily
identified as epithelial subtypes: Cluster 2 exclusively expressed
Krt5, Krt14 (Figure 2B), and Krt17, recognized markers of
basal epithelial cells. Cluster 11, physically separate from the
other epithelial clusters in the Seurat PCA analysis (Figure 2A),
exclusively expressed many genes characteristic of ciliated cells
(Hoh et al., 2012), including those encoding dynein axosomal
heavy (e.g., Dnah5) Intermediate and light chains, the dynein
regulator Dynlrb2 (dynein light chain roadblock 2) as well as
Hydin (axonemal central pair apparatus protein) (Figure 2B).
Melanocytes
Embedded within the larger epithelial cell grouping that included
Clusters 0, 1, 2 and 6 was a small number of cells (Cluster 16,
consisting of only 1.8% of all cells) that did not express epithelial
markers. The cells of this cluster uniquely expressed markers
for melanocytes (Yang et al., 2014), including many involved
in melanin synthesis: Pmel (premelanosome protein), Mlana
(melan-A) which is required for PMEL function, Dct (dopamine
tautomerase, involved in PMEL synthesis), Slc45a2 (Solute carrier
family 45 member 2) involved in melanin synthesis and Tyrp1
(tyrosine-related protein 1) which regulates melanin synthesis).
Stromal Cells
After epithelial cells, the next largest group of cells (22.6% of
all cells) expressed genes typical of stromal cells. This included
Clusters 3, 4, and 5 (Figure 2A), the cells of which expressed
numerous extracellular matrix (ECM)/connective tissue proteins,
such as Col1a1 (collagen type 1 alpha 1), Col1a2 (Figure 2C),
Fbln1 (fibulin 1, a fibrillar ECM), Wisp2 (Wnt1 inducible
signaling pathway protein, a connective tissue growth factor);
Adamts5 (ADAM metallopeptidase with thrombospondin type
1), a connective tissue organization factor, Fmod (fibromodulin)
TABLE 2 | Genes used to identify ME cell types.
Epithelial cells (all) Epcam, Krt18, Krt19
Basal Krt5, Krt14
Ciliated Spag6l, Hydin
Secretory Muc1, Lyz
Stromal cells (all) Col1a2
Endothelial cells Egfl7
Vascular Flt4
Lymphatic Flt1
Pericytes Rgs5
Melanocytes Mlana
Monocytes (all) Csf1r
Macrophages Adgre1 (F4/80)
M2 C1qa
Dendritic cells Itgax
Cytotoxic phenotype Klrk1
Lymphocytes (all) Ptprcap
T-cell Cd3d
B-cell Cd79a
Type 2 Lymphoid cell Areg
These genes were reliable indicators of cell types in the normal ME.
collagen fibrillogenesis factor involved in ECM assembly, and
Cdh11 (cadherin 11), an ECM synthesis regulator.
Endothelial Cells and Pericytes
Cells associated with the vasculature comprised 9.2% of all cells
on our samples. Clusters 7 and 12 exclusively expressed the
endothelial cell marker Egfl7 (encoding a secreted endothelial
protein involved in angiogenesis) (Figure 2D). They were
also the only cells expressing several other genes related to
angiogenesis including Lrg1 (A TGF-beta binding protein),
Mmrn2 (A TGF-beta antagonist), Rasip1, Vegfr2, and Sox18.
In addition, they expressed Selp (P selectin) and Icam2,
both involved in endothelial recruitment of leukocytes. The
cells of Cluster 13 expressed marker genes for pericytes,
including Rgs5 (Figure 2D), a hypoxia-inducible G-protein
regulatory subunit involved in angiogenesis and regulation of
leukocyte extravasation.
Monocytes
Monocyte lineage cells comprised 8.52% of our samples. The cells
of Clusters 8 and 9 uniquely expressed many monocyte marker
genes, including Csf1r (colony stimulating factor 1 receptor)
(Figure 2E), Aif1 (monocyte activation) c300d (receptor involved
in innate immunity), Lst1 (lymphocyte proliferation inhibitor),
Clec12a (negative regulator of monocyte and granulocyte
function) and Ccl2 (macrophage chemoattractant). Cluster 8 cells
also exclusively expressed macrophage-specific markers, such as
Adgre1 (F4/80 antigen) (Figure 2E), Ccl3 (MIP1alpha) and Mrc1
(macrophage mannose receptor). Many but not all cells in Cluster
9 preferentially expressed Itgax (mature dendritic cell marker)
(Figure 2E) and Cd209a (dendritic cell adhesion molecule),
consistent with dendritic cell identity. The non-macrophage,
non-dendritic cell monocytes were a mixed population of
Frontiers in Genetics | www.frontiersin.org 6 April 2020 | Volume 11 | Article 358
fgene-11-00358 April 9, 2020 Time: 15:55 # 7
Ryan et al. Middle Ear Single Cell Transcriptomes
FIGURE 3 | Immunohistochemical localization of select proteins encoded by marker genes, used to identify cell types in the ME mucosa. Paraffin sections were
labeled with phalloidin (red), DAPI (blue) and Alexa 488-conjugated secondary antibodies (green). The upper six panels represent marker genes used to identify cell
types known to be present in the ME. The three lower panels represent less expected findings: DEFB1 expression in basal epithelial cells; AREG indicating type II
lymphoid cells; and ECRG4, often expressed in epithelia, in stromal cells. Scale bars represents 100 µm.
inflammatory (Ccr2+, Ly6C2+) and resident, homeostatic
(Cx3cr1+, Ly6C2−) phenotypes (Gordon and Taylor, 2005).
Lymphocytes
The lymphocytes of Clusters 10, 14, and 15 (comprised 6.2%
of our samples. All exclusively expressed a murine lymphocyte-
specific gene Ptprcap (encoding a key regulator of lymphocyte
activation) (Figure 2F). Cluster 10 cells also expressed Cd2 and
Cd28 (Figure 2F), markers of both T- and NK-cells. The cells
of Cluster 14 did not express specific T-cell or B-cell markers.
However, they exclusively expressed Areg (Figures 2F, 3), an
immunoregulatory member of the EGF family which is produced
by type 2 innate lymphoid cells (ILC2s) (Zaiss et al., 2015).
Consistent with an ILC2 phenotype, they also expressed Il7r and
Thy1, Il13, and Gata3 (Gasteiger et al., 2017). Cluster 15 cells
expressed B-cell markers including Cd19, Cd79a (Figure 2F)
and Cd79b (involved in B-cell antigen recognition), H2-dmb2 (a
B-cell class II molecule), Mzb1 (which regulates Ca2+ stores to
diversify B-cell function).
The expression of selected genes used to identify ME cell
types is further illustrated by immunohistochemical labeling
in Figure 3.
Differential Expression of Genes
by ME Cell Clusters
The above analysis employed marker genes to identify cell types
in our ME samples. However, the majority of the genes that were
significantly differentially expressed between clusters, and which
defined them in PCA analysis, were not markers for a given cell
type. A total of 2,207 genes were differentially expressed between
Seurat t-SNE clusters. For purposes of illustration, Figure 4 shows
a heat map of the top 5 genes that were differentially regulated
between each of the various clusters, and that contributed to
cluster generation. It can be seen from the figure that most
clusters expressed gene sets that clearly differentiated them from
other cell groups. Genes that were highly expressed by different
ME cell types, either exclusive to that type (as defined previously)
or strongly preferentially, are described below.
Epithelial Cells
Many of the genes exclusively expressed by cells in all five ME
epithelial populations are involved in fluid or solute regulation,
including Aqp5, Cldns 3, 4, and 7, Fxyd3, Kcnj16; Atp1b1, Fxyd3
and Slc6a1.
The cells of Clusters 0, 1, and 6 appeared to be closely related
and expressed relatively few genes exclusively. Rather, this group
of clusters expressed genes in common, often exhibiting relative
differences in expression. A number of genes were expressed
in these clusters in a gradient, with the descending order 1, 6
and 0. This included Muc1 (Figure 2B), Muc5b, Muc16, Tff2
(Trefoil factor 2, mucin stabilization gene), Reg3g (secreted
lectin), as well as Lyz2 (lysozyme) and Ltf (lactotransferrin),
both antimicrobials. Also expressed with this gradient were
Agr2 (anterior gradient 2) involved in mucin assembly and
Mgst1 (microsomal glutathione S-transferase 1) involved in
leukotriene and prostaglandin synthesis. These gene gradients
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FIGURE 4 | Heatmap illustrating the 5 most differentially regulated genes for each of the 17 Seurat cell clusters. Most clusters were clearly delineated by the
differential gene expression. However, three epithelial clusters (0, 1, and 6) showed somewhat overlapping patterns of expression.
are consistent with Cluster 1 cells exhibiting the highest level
of secretory activity. Cluster 1 cells also expressed high levels
of Upk1b, involved in the stabilization and strengthening of
apical cell membranes, suggesting presence at the luminal
surface of the mucosa.
Genes expressed with an opposite gradient, highest in Cluster
0 and lowest in Cluster 1, included Bcam and Igfbp5, involved
in ECM binding, and Sftpd (Figure 2B) encoding surfactant
protein D. Genes that defined Cluster 6 included Cyp4a12a (iron
binding oxyreductase), Mal (vesicle trafficking from Golgi), Lcn2
(iron sequestration), Bex1 (growth factor signaling) and Foxe1
(transcription factor involved in TGF and WNT regulation).
However, these genes were also expressed in Clusters 0, at higher
levels than in Cluster 6, and to a lesser extent in Clusters 1 and 2
(see Figure 4).
The basal epithelial cells of Cluster 2 cells strongly expressed
Sfn (a regulator of cell signaling and cell cycle), Aqp3, Dapl1 (G
coupled receptor activity), and Anax8. Aquaporin 3 is found in
the basolateral membranes of kidney collecting duct cells, where
it provides a pathway for water to exit these cells. This may play a
similar role in the exit of water from the ME mucosal epithelium
at its basal surface. Annexin 8 is a calcium binding protein found
in mature and functional epithelial cells, where it participates in
exocytosis. Interestingly, basal epithelial cells were also the only
ME cells to strongly express Defb1, encoding the antimicrobial,
beta defensin 1 (Figure 3).
In addition to many genes related to cilia, the ciliated
epithelial cells of Cluster 11 exclusively expressed Muc4, encoding
a membrane mucin that can activate ERBB2 and stimulate
epithelial proliferation. They also preferentially expressed an
unusually high number of genes for which no function has
been well described, including among others Tmem212, Ccdc153,
C9orf116, Fam183b, Sec14l3, and antisense IncRNA AU40972.
Stromal Cells
Cluster 3 was distinguished from other clusters by significantly
higher levels of expression of growth regulators, including Ecrg4
(epithelial cell growth regulator) (Figures 2C, 3) which in other
tissues is often expressed in epithelial cells (Kurabi et al., 2013),
Sfrp2 (Wnt signaling modulator), Serpinf1 (angiogenesis and cell
differentiation inhibitor) and Aspn (TGFß and BMP inhibitor).
Cluster 4 exclusively expressed Adam33 (cell−ECM
interactions) (Figure 2C), Dpt (ECM assembly) and Col28a1
(collagen chain trimerization). The cluster preferentially
expressed other genes related to ECM generation: including Gpc6
(growth factor and ECM receptor), Dcn (ECM assembly), Mfap4
and Mfap5 (ECM proteins); as well as genes involved in defense
against infection: Cxcl13 (anti-microbial, B-cell chemoattractant)
and Adm (antimicrobial and fluid regulation).
The cells of Cluster 5 strongly expressed Mmp13 (ECM
breakdown), Serpine2 (regulator of cell signaling) and Timp1
(MMP inhibitor). They also exclusively expressed several genes
consistent with osteoblast function, including Bglap (an abundant
Ca-binding bone protein) (Figure 2C), Bglap2 (a hormone
secreted by osteoblasts), Ibsp (a major structural protein in bone)
and Sfrp4 (involved in bone morphogenesis), as well as Tnc (ECM
protein tenascin C), Podnl1 (collagen binding), and Ackr4 (a
decoy receptor that inactivates cytokines).
Endothelial Cells
Of the two groups of endothelial cells, Cluster 7 strongly
expressed Aqp1, Ly6c1 (an immunocyte antigen also expressed
by endothelial cells), Lrg1 (TGFß receptor binding) and Plvap
(microvascular permeability). They exclusively expressed Flt1
(VEGFR1) (Figure 2D), Aplnr and Vwf (Von Willebrand
factor), consistent with vascular endothelium, as well as the
scavenger cytokine receptor Ackr1. Cluster 12 cells exclusively
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expressed Prox1 (a homeobox protein), Flt4 (VEGF receptor 3)
and Reln (Reelin), all markers for lymphatic endothelial cells,
as well as Ccl21a (T-cell chemotaxis), Cldn5 (tight junction
protein), Gm525 (unknown function), Ptx3 (angiogenesis and
inflammation), Mmrn1 (a factor V/Va receptor) (Figure 2D) and
the cytokine scavenger receptor gene Ackr2.
Pericytes
The pericytes of Cluster 13 exclusively expressed three hypoxia-
inducible mitochondrial genes involved in regulating the shift
between glucose and glycogen metabolism: Higd1b; Ndufa4l2
and Cox4i2. They were the only ME cells to express genes
involved in regulating vascular tone, including Des, Olf558,
Myh11, Myocd and Kcne4 (Jepps et al., 2015). They also expressed
Cspg4, encoding a proteoglycan that stimulates endothelial
cell motility during microvascular morphogenesis and Ephx3,
encoding a protein involved in water permeability barriers. They
strongly expressed GM13889 (unknown function) and Mustn1
(muscle development).
Macrophages
The macrophages of Cluster 8 preferentially expressed genes
observed in M2 (alternatively activated) macrophages, such as
those encoding the complement components C1qa (Figure 2E),
C1qb and Ciqc and the fractalkine receptor Cx3cr1 (Italiani
and Boraschi, 2014). They also strongly expressed Cxcl2
(macrophage inflammatory protein 2), Pf4 (neutrophil and
monocyte chemotaxis) Tyrobp (neutrophil activation), Plbd1
(hydrolase activity) and Spi1 (macrophage differentiation).
Interestingly, none of the cells in this clusters expressed the
mature macrophage marker Itgam (MAC-1), but many expressed
Cd33, characteristic of immature macrophages.
Dendritic Cells/Monocytes
Most of the cells in Cluster 9 preferentially expressed Itgax
(mature dendritic cell marker) and Cd209a (dendritic cell
adhesion molecule), consistent with dendritic cell identity.
However, these cells also expressed the NK gene Klrk1
(Figure 2E). This indicates that they are primarily NK dendritic
cells, which possess cytotoxic capability. These cells are usually
present as a small subset of dendritic cells in blood and tissue
(Chan et al., 2006), but appear to represent about 40% of
dendritic cells (Itgax+) in the ME. In common with Cluster
8, the dendritic cells and monocytes of Cluster 9 strongly
expressed Tyrobp, Plbd1 and Spi. They also exclusively expressed
Cd209a (pathogen receptor). As noted above, less differentiated
monocytes expressed genes consistent with either the classical
(pro-inflammatory) or resident (homeostatic) phenotypes.
Lymphocytes
Many of the lymphocytes of Clusters 10 expressed the T-cell
receptor genes Cd3d and Cd3g, as well as CD3e and Cd3z,
indicating that they are gamma/delta T-cells. Consistent with
this identity, very few expressed Cd4. Gamma/delta T-cells are
common in mucosal and other barrier tissues where they serve
as part of the front-line defense against infection. Many also
expressed Nkg7 (a natural killer cell granule protein) suggesting
a cytotoxic phenotype. A small subpopulation expressed Cd8a
and Cd8b1. Cd8ab-positive gamma-delta T-cells have been
identified as a unique cytotoxic population that is negatively
correlated with disease states (Kadivar et al., 2016). The larger
population of Cd8−/Cd4− cells are known as double-negative
T-cells. In other tissues, the majority of double-negative T-cells
bear the alpha/beta receptors consistent with cognate immunity
(Antonelli et al., 2006). However, in the ME mucosa the majority
appear to bear the gamma/delta receptor more consistent with
innate immune function. Gamma/delta T-cells are also involved
in M2 macrophage polarization (Mathews et al., 2015). Cluster
10 cells also strongly expressed Ms4a4b, a negative regulator of
T-cell proliferation.
The ILC2 cells of Cluster 14 type exclusively expressed Il5
and Il13, Th2 cytokines associated with this cell type, as well
as Il1rl1 and Icos, which have been associated with helper cell
function, and Cxcr6, associated with memory, naïve (Cd28+) and
regulatory (Il7r+) T-cells. They also strongly expressed, Il1rl1
(possibly helper T-cell function), Ccdc184 (unknown function),
and Calca (calcium regulation, antimicrobial).
The B-cells of Cluster 15 expressed many genes related
to B-cell function, including Cd22 (essential for B-cell−B-cell
interactions); Dank1 (mobilization of intracellular B-cell stores);
Spi6 (B-cell development); Pou2af1 (essential for B-cell response
to antigens), Ms4a1 (B-cell development) and various Fc receptor
genes involved in B-cell activation. They also expressed Pax5,
involved in early but not late B-cell development, suggesting that
ME B-cells are not fully mature. A small number of cluster cells
expressed Jchain, involved in the production of secretory factor.
In addition to evaluating differentially expressed genes,
we applied an analysis of the GO: biological processes the
genes for which were most highly expressed by different cell
clusters. Not surprisingly the results summarized in Table 3, are
largely consistent with functions that can be inferred from the
differentially regulated genes presented above.
Expression of Innate Immune Genes
by ME Cell Types
The genes reviewed above were identified based purely on
differential expression across cell clusters. In order to evaluate the
expression of genes specifically related to OM, we first assessed
genes related to innate immunity across ME cell clusters and
types. Acute OM in the average child resolves in less than one
week (Little et al., 2001). This is not sufficient time to mount
a robust cognate immune response, which implies that normal
resolution of acute OM is mediated by innate immunity. Indeed,
studies in mice with deletions of individual genes for innate
immune receptors or effectors have found that, while lack of some
genes leads to more severe deficits in recovery from bacterial
OM, virtually all show a deficit (Kurabi et al., 2016). This finding
indicates that the innate immune system participates in normal
OM recovery, and that the genetic machinery with which to
initiate innate immunity resides in the cells of the normal ME. We
therefore evaluated the expression of genes in Mouse Genome
Informatics GO category 0045087 “Innate Immunity.” Out of
809 genes in the category, expression of 805 was detected in cells
of the normal ME.
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TABLE 3 | Single-cell cluster enrichment of GO: biological process.
GO category P-value
Cluster 0 (Epithelial cells)
Negative regulation of cell motility 2.0631e−7
Negative regulation of cell migration 9.0561e−7
Extracellular matrix organization 8.8733e−8
Negative regulation of cellular component movement 3.3807e−7
Negative regulation of locomotion 6.5930e−7
Cluster 1 (Epithelial cells)
Extracellular matrix assembly 0.0000088218
Collagen metabolic process 0.0000034043
Extracellular matrix organization 4.0817e−9
Extracellular structure organization 2.7391e−8
Cell growth 0.0000029102
Cluster 6 (Epithelial cells)
Protein trimerization 0.00018877
Cellular response to amino acid stimulus 0.000026320
Cellular response to acid chemical 0.000072229
Lung development 0.00018877
Respiratory tube development 0.00022526
Cluster 2 (Basal epithelial cells)
Collagen biosynthetic process 0.000040927
Collagen metabolic process 0.00018409
Protein localization to plasma membrane 0.000059560
Bone mineralization 0.000055506
Transforming growth factor beta receptor signaling pathway 0.000045449
Cluster 11 (Ciliated epithelial cells)
Axoneme assembly 0
Cilium movement 0
Cilium or flagellum-dependent cell motility 1.9154e−10
Cilium-dependent cell motility 1.9154e−10
Axonemal dynein complex assembly 1.9154e−10
Cluster 3 (Stromal cells)
Collagen fibril organization 0.0000091862
Collagen metabolic process 0.0000037847
Protein processing 0.000068852
Extracellular matrix organization 4.5168e−9
Extracellular structure organization 7.6653e−8
Cluster 4 (Stromal cells)
Collagen fibril organization 0.0000043023
Embryonic skeletal system development 0.000014268
Negative regulation of cellular response to growth factor
stimulus
0.0000039117
Collagen metabolic process 0.0000068214
Extracellular matrix organization 3.7315e−11
Cluster 5 (Stromal cells)
Collagen fibril organization 1.5268e−9
Regulation of bone mineralization 5.1255e−8
Regulation of biomineral tissue development 6.3049e−9
Bone mineralization 7.6798e−10
Biomineral tissue development 1.7298e−11
Cluster 7 (Vascular endothelial cells)
Negative regulation of cellular component movement 2.5616e−8
Regulation of plasma membrane bounded cell projection 4.2233e−8
Regulation of cell projection organization 5.2664e−8
(Continued)
TABLE 3 | Continued
GO category P-value
Angiogenesis 6.4595e−11
Blood vessel morphogenesis 9.2663e−11
Cluster 12 (Lymphatic endothelial cells)
Endothelial cell differentiation 0.0000057055
Endothelium development 0.0000080317
Sprouting angiogenesis 0.000010961
Negative regulation of angiogenesis 0.0000091829
Negative regulation of blood vessel morphogenesis 0.000013967
Cluster 13 (Pericytes)
Membrane repolarization 0.000084352
Actin-mediated cell contraction 0.0000096969
Actin filament-based movement 0.000018559
Notch signaling pathway 0.0000090719
Regulation of heart contraction 0.00017208
Cluster 8 (Macrophages)
Tumor necrosis factor production 5.0342e−8
Regulation of tumor necrosis factor production 3.3417e−8
Cellular response to molecule of bacterial origin 4.9622e−8
Response to molecule of bacterial origin 2.1447e−8
Response to organonitrogen compound 3.3417e−8
Cluster 9 (Monocytes, Dendritic cells)
Cellular response to radiation 0.000033926
Activation of innate immune response 0.000071442
Tumor necrosis factor production 0.000017344
Regulation of tumor necrosis factor superfamily cytokine
production
0.000043714
Tumor necrosis factor superfamily cytokine production 0.000043714
Cluster 10 (T-cells, NK cells)
T-cell receptor signaling pathway 5.3595e−7
Positive regulation of leukocyte cell-adhesion 3.9513e−7
Positive regulation of lymphocyte activation 2.3319e−7
T-cell differentiation 9.7306e−8
T-cell activation 4.4670e−12
Cluster 14 (ILC2s)
Positive regulation of leukocyte differentiation 0.0000018086
Regulation of lymphocyte differentiation 0.0000011529
Positive regulation of hemopoiesis 0.0000013987
Positive regulation of lymphocyte activation 0.000002159
Regulation of hemopoiesis 1.1023e−7
Cluster 15 (B-cells)
B cell receptor signaling pathway 2.9347e−11
Regulation of B cell proliferation 7.1741e−8
B cell proliferation 3.0189e−8
B cell activation 6.8834e−15
Antigen receptor-mediated signaling pathway 2.8936e−9
Cluster 16 (Melanocytes)
Sister chromatid segregation 8.2230e−10
DNA packaging 2.8980e−9
DNA conformation change 5.2742e−10
Chromosome segregation 9.2013e−11
Nuclear chromosome segregation 1.4193e−9
The five GO categories with the highest enrichment ratios are listed for each single-
cell cluster.
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For a few genes, there was broad expression across all
ME cell types. These included Bipfa1 (contributes to airway
surface liquid homeostasis and proper clearance of mucus)
as well as three ribosomal proteins with innate immune
subfunctions: Rpl13a (suppression of inflammatory genes);
Rpl39 (viral gene transcription) and Rps19 (suppression of
interferon production).
For a total of 520 innate immune genes, there were significant
expression differences between cell types. A heat map illustrating
the expression of the 520 genes across all ME cells is presented in
Supplementary Figure S1, while Figure 5 shows the expression
of a more readily visualized set of 109 innate immune genes,
those with the most robust expression, ordered by cell type.
Table 4 lists the most differentially expressed innate immune
genes for each cell cluster. All clusters expressed distinct sets of
innate immune genes.
The epithelial cells of Cluster 0 expressed Lbp (component
of the endotoxin receptor), Lcl2 (antibacterial protein) Sftpd
(surfactant protein D), Xrcc5 (antiviral response) Cd55 (negative
complement regulator) and Hmgb2 (innate immune DNA/RNA
receptor). They also expressed genes related to leukocyte
recruitment and activation, including Csf1 (macrophage
differentiation) and Cxcl16 (T-cell recruitment). Cluster 1
epithelial cells expressed the genes for the anti-microbials
lactoferrin and REG3γ, and the interferon-stimulated antivirals
CD25 and ISG20. The basal epithelial cells of Cluster 2 expressed
several complement genes, as well as Axl (TLR inhibition), Rab20
(antibacterial response), and the anti-viral gene Ifit1. Cluster
6 epithelial cells expressed Sftpd. The ciliated epithelial cells
of Cluster 11 expressed a small set of diverse innate immune
genes including Hist1b2bc (antibacterial responses), Il1rn1
(receptor-blocking inhibitor of IL1ß), Ifit1, and Aqp4.
Innate immune genes expressed by all stromal cells of Clusters
3, 4 and 5 included Colec12, (antimicrobial response), Mmp2
(positive regulator of inflammatory NFκB signaling), Rarres2
(chemotactic and anti-inflammatory factor), and Serpinb1
(negative complement regulation). Clusters 3 and 4 uniquely
expressed several complement factors and Lgals9 (soluble,
negative regulator of T- and NK-cells). Cluster 4 expressed the
complement factor gene C2. Clusters 3 and 5 expressed Cfn
(negative complement regulator), while Cluster 5 expressed
Tgfb1 (multifunctional, including inhibition of T-cell Th1, Th2
and cytotoxic phenotypes) and Tspan6 (negative regulator of
innate immunity).
The vascular endothelial cells of Clusters 7 expressed Adam15
(epithelial−T-cell interactions) Cav1 (T-cell activation, negative
regulation of TGFß1), Cebpg (IL4 gene activation), Dab2ip
(participates in TNF, IFN and LPS signaling pathways), Iigp1
(IFN-inducible antimicrobial), Irf1 (IFN production), Irgm1
(IFN-induced negative regulator of mucosal immune responses),
Vim (viral and bacterial attachment) and Samhd1 (response to
virus, mediation of TNF response).
The lymphatic endothelial cells of Cluster 12 strongly
expressed Tspan6, Mrc1, Ccl21a (all described above) as well as
Bst2 (antiviral), Arrb2 (involved in multiple signaling pathways
including that of CCL19), Ptx3 (positive regulation of innate
response to pathogens) and Serinc3 (resistance to viral infection).
The pericytes of Cluster 13 expressed the complement gene
C1s1, Cav1 (negative regulator of inflammation) and Ifitm1.
Some of the innate immune genes expressed by Cluster 8
macrophages are marker genes for this cell types, as noted above.
Also expressed preferentially by this cell type were nine genes
related to pathogen receptor signaling, a total of ten chemotactic
chemokine genes, four genes related to complement response, six
immune modulators including four negative regulators and the
antibacterial gene Scl11a1.
Cluster 9 monocytes and dendritic cells preferentially
expressed a subset of the genes expressed by Cluster 8
macrophages, but also expressed two genes encoding NK cell
lectins related to cytotoxicity, Klrd1 and Klrk1; Lgals3 (PMN
and mast cell activation, macrophage chemotaxis); Rnase6
(antibacterial); Samhd1 (antiviral responses); Sirpa (negative
regulation of dendritic cells and phagocytosis); Slamf7 (killer cell
activation); and Unc93b1 (intracellular TLR transport).
The T-cells and NK cells of cluster 10 strongly expressed
Coro1a (required for lytic granule secretion from cytotoxic cells),
Klrd1, Klrk1, Ccl5 (leukocyte chemoattractant or chemotaxis
inhibitor, depending on splicing), Hmgb2 (innate immune
DNA/RNA receptor), Rpl14a (ribosomal protein upregulated
by endotoxin, Ceppi et al., 2009) and Txk (involved in Th1
cytokine production). The ILC2s of Cluster 14 expressed Cor1a,
Samhd1, Ccl1 (monocyte chemotaxis), Arg1 (promotes acute type
2 inflammation), and C1qbp (involved in multiple infection and
inflammatory responses). The B cells of Cluster 15 expressed
Cd74 (MIF receptor), Corol1a, Irf8 (regulates IFN responses),
Ly86 (involved in endotoxin response with TLR4), Ptpn6
(hematopoietic cell signaling), Slamf7 (NK cell activation) and
Unc93b1.
The melanocytes of Cluster 16 strongly expressed Vim,
Gapdh (in innate immunity, IFNg-induced transcript-
selective translation inhibition) and Mif (regulation of
macrophage function).
DISCUSSION
The results of this study provide, for the first time, a molecular
landscape of the cells that make up the normal mucosal lining
of the ME prior to OM. They also identify the resting ME cells
that express major determinants of innate immunity. As noted
above, innate immunity is responsible for the normal resolution
of OM (e.g., Underwood and Bakaletz, 2011; Kurabi et al., 2016).
The immediate response provided by the cell of the normal ME is
critical to initiating this first line of defense against infection. We
found that the cells of the ME have distinctly different potential
capacities to contribute immediately to innate immunity. Our
results also provide a baseline against which to measure the
responses of ME cells to infection in future studies.
Cell Types of the Normal ME
Seurat PCA analysis of 6,370 ME cells identified 17 cell clusters,
each of which displayed a distinct set of genes. The expression of
key genes by most of these clusters correspond to cell types that
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FIGURE 5 | Heatmap illustrating the expression of the 109 most differentially regulated innate immune genes, arranged by cell cluster in which they are differentially
expressed. Cluster 8 cells (macrophages) expressed the greatest number.
have been observed previously in the ME, while others identify
cells not previously known to be present.
Epithelial Cells
As noted above, previous authors have proposed five (Lim and
Hussl, 1969; Lim, 1979) or six (Hentzer, 1976) morphological
categories of ME epithelial cells: basal, intermediate, non-
secretory, intermediary secretory, secretory and ciliated
epithelial cells. Our transcriptome data are more consistent
with five subtypes. Of the five clusters of cells expressing
epithelial markers, basal (Cluster 2) and (Cluster 11) ciliated
epithelial cell clusters were clearly identified. The three
remaining clusters, 0, 1, and 6, were less differentiated by
gene expression and presumably less specialized. However,
Cluster 1 showed the highest expression of genes encoding
secreted factors, including mucins, indicating that this cluster
likely consists of fully developed secretory epithelial cells.
Secretory genes were expressed at progressively lower levels
in Clusters 6 and 0. However, Cluster 0 exclusively expressed
surfactant D, also suggestive of an epithelial surface location,
and the most innate immune genes of any epithelial type,
indicating a prominent role in initial defense of the ME. This
cluster may thus represent the morphologically defined “non-
secretory” surface epithelial cells. Cluster 6 gene expression was
intermediate between that of Clusters 0 and 1, consistent with an
intermediate epithelial cell capable of transitioning into either of
these two phenotypes.
Regarding the two disparate origins of ME epithelial cells
noted by Thompson and Tucker (2013), neural crest versus
branchial arch endoderm, there are no recognized adult gene
markers for cells of neural crest origin. The small number
of melanocytes observed in Cluster 16, which were scattered
through epithelial clusters in the Seurat analysis and are assumed
to be of neural crest origin (Lin and Zak, 1982), did not
express epithelial markers. In addition, we saw no categories
of ME epithelial cells that might reasonably be supposed to
correspond to this division. It seems likely that dissection of
the ME mucosa from the corresponding regions prior to single-
cell analysis would be required to determine whether different
embryologic origins correspond to any transcriptome and/or
functional variations.
Stromal Cells
Based on their morphology, ME stromal cells have generally been
classified as fibrocytes, with little further distinction. Clusters
3, 4, and 5 were identified as stromal by the expression of
many ECM genes. Cluster 5, expressing bone formation genes,
appears to correspond to osteoblastic cells. The ME has a
strong propensity to generate new bone beneath the stromal
layer during OM (Cayé-Thomasen et al., 1999). Cluster 3
was characterized by preferential expression of genes targeting
tissue growth, including that of epithelial cells, while cluster 4
expressed genes encoding antimicrobials. These clusters indicate
the presence of two additional classes of stromal cells in the
ME, cell types not previously recognized on morphological or
histochemical grounds.
Vascular Cells
Blood vessels, although sparse in the ME, have long been
recognized (Lim, 1979). Therefore the vascular endothelial cells
of Cluster 8 were to be expected. Morphological studies have
also noted the presence of lymphatics in the ME based (Lim and
Hussl, 1975), and drainage from the ME to lymph nodes of the
neck has been demonstrated (Galich, 1973; Lim and Hussl, 1975),
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TABLE 4 | Single-cell Cluster Expression of Innate Immune Genes.
Gene Protein Innate immune function
Cluster 0 (Epithelial cells)
Lbp LPS Binding Protein Endotoxin receptor
component
Hmgb2 High mobility group box 2 Innate immune DNA/RNA
receptor
Csf1 Colony stimulating factor 1 Macrophage differentiation
Cxcl16 Chemokine CXCL16 T-cell recruitment
Ptpn2 PTP2 T-cell activitation, tissue
growth
Cadm1 CADM1 NK and T-cell regulation by
other cell types
Cd24a CD24A B-cell differentiation, tissue
growth
Lcn2 Lipocalin2 Antibacterial
Sftpd surfactant D Antibacterial, surfactant
Xrcc5 DNA repair XRCC5 Antiviral
Cd55 DAF Negative complement
regulator
Cluster 1 (Epithelial cells)
Cd25 IL2 receptor α Control of regulatory T-cell,
tissue growth
Ppp1r1b PPP1R1B Regulatory T-cell activation,
cell survival
Ltf Lactoferrin Antimicrobial
Reg3γ REG3γ Antimicrobial
Isg20 ISG20 IFN-stimulated antiviral
Cluster 6 (Epithelial cells)
Sftpd surfactant D antibacterial, surfactant
Cluster 2 (Basal epithelial cells)
Lbp LPS Binding endotoxin receptor
component
Hmgb2 High mobility group box 2 innate immune DNA/RNA
receptor
Cadm1 CADM1 NK and T-cell regulation by
other cell types
Gata3 GATA3 Immune cell differentiation,
tissue growth
Rab20 RAB20 endocytosis, antibacterial
responses
Xrcc5 DNA repair XRCC5 antiviral response
Ifitm1 IFITM1 Inhibition of viral entry
Rpl39 Ribosomal protein L39 Viral gene transcription
Rpl13a Ribosomal Suppression of
inflammation
Rps19 Ribosomal Suppression of interferon
Axl AXL receptor tyrosine kinase TLR inhibition
Cd55 DAF negative complement
regulator
Cluster 11 (Ciliated epithelial cells)
Adam8 ADAM8 leukocyte migration
Cd24a CD24A B-cell differentiation, tissue
growth
Ifitm1 IFITM1 inhibition of viral entry
Aqp4 Aquaporin4 water
permeability,response to
inflammation
(Continued)
TABLE 4 | Continued
Gene Protein Innate immune function
Clusters 3, 4, 5 (All stromal cells)
Gsn Gelsolin TLR endocytosis
Rarres2 Chemerin Chemotactic,
anti-inflammatory
C1ra Complement C1 component Complement response
Colec12 Collectin-12 Antimicrobial responses
Serping1 Serpin G1 Negative complement
regulator
Axl AXL receptor tyrosine kinase TLR inhibition
Cluster 3 (Stromal cells)
C1s1 Complement C1 component Complement response
Cr1l C1 receptor like Complement activation
Samhd1 SAMHD1 Mediates TNF inflammatory
responses
Lgals9 Galactin9 Negative regulation of
T- and NK-cells
Ifitm1 IFITM1 Inhibition of viral entry
Clec2d CLEC2D Protection against NK cell
lysis
Cluster 4 (Stromal cells)
C1s1 Complement C1 component Complement response
C2 Complement C2 Complement response
C3 Complement C3 Complement response
Apoe Apolipoprotein E Leukocyte regulation, lipid
metabolism
Zyx Zyxin Viral pathogen receptor
signaling
Bst2 Tetherin Antiviral
Serinc3 Serine incorporator 3 Antiviral
Trp53 P53 Antiviral
Ifitm1 IFITM1 Inhibition of viral entry
Lgals9 Galectin 9 Negative regulator of T- and
NK-cells
Cluster 5 (Stromal cells)
Lgals3 Galectin 3 Acute inflammation
activator
Csf1 Colony stimulating factor 1 Macrophage differentiation
Trp53 P53 Antiviral
Tgfb1 TGFβ1 Multifunctional,
immunocyte inhibition
Tspan6 Tetraspanin 6 Negative innate immune
regulator
Cluster 7 (Vascular endothelial cells)
Vim Vimentin Viral and bacterial
attachment
Samhd1 SAMHD1 Mediates TNF inflammatory
responses
Dab2ip DAB2 interacting protein TNF, IFN and LPS signaling
pathways
Irf1 IFN response factor IFN production
Adam15 ADAM15 Epithelial−T-cell interaction
Cav1 Caveolin 1 T-cell activation, TGFß1
inhibition
Iigp1 IFN-inducible G Protein 1 IFN-inducible antimicrobial
Cebpg CEBPG IL4 gene activation
(Continued)
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TABLE 4 | Continued
Gene Protein Innate immune function
Irgm1 IRGM1 Mucosal immune response
inhibition
Cluster 12 (Lymphatic endothelial cells)
Mrc1 Mannose receptor C1 Pathogen neutralization
Ptx3 Pentraxin 3 Positive regulation of innate
immunity
Ccl21 Chemokine CCL21 T-cell chemotaxis
Arrb2 Arrestin β2 Cytokine/chemokine
signaling pathways
Bst2 Tetherin Anti-viral
Serinc3 Serine incorporator 3 Antiviral
Tspan6 Tetraspanin 6 Negative innate immune
regulator
Cluster 13 (Pericytes)
C1s1 Complement C1 component Complement response
Cav1 Caveolin 1 T-cell activation, TGFß1
inhibition
Ifitm1 IFITM1 Inhibition of viral entry
Cluster 8 (Macrophages)
Tlr2 Toll-like receptor 2 Pathogen receptor
Cd14 CD14 LPS receptor component
Ly86 MD-1 LPS receptor component
Nlrp3 NALP3 Pathogen receptor,
inflammasome
MyD88 MYD88 TLR signaling adaptor
Mrc1 Mannose receptor C1 Pathogen neutralization
Unc93b1 UNC93B1 Required for TLR DNA
recognition
Cfp Complement factor P Alternative complement
response
C1qa,b,c Three C1q A-chains Complement response
Irf5, Irf8 IFN response factors IFN production
Cd86 CD86 T-cell activation, IL2
production
Actr3 ACTR3 Phagocytosis
Trem2 TREM2 Immune activation in
phagocytes
Cd74 CD74 MHC class II antigen
processing
Clec4a2 Lectin-like immunoreceptor Antigen presentation
Apoe Apolipoprotein E Macrophage, T- and
NK-cell regulation
Arrb2 Arrestin β2 Cytokine/chemokine
signaling pathways
Ccl2 Chemokine CCL2 Macrophage chemotaxis
Ccl3 Chemokine CCL3, MIP1α Monocyte, PMN
chemotaxis
Ccl4 Chemokine CCL4, MIP1β NK cell, monocyte
chemotaxis
Ccl5 Chemokine CCL5, RANTES T-cell chemotaxis
Ccl9 Chemokine CCL9, MRP2 Dendritic cell chemotaxis
Cxcl16 Chemokine CXCL16 T-cell, NK-cell chemotaxis
Coro1a Coronin 1A Lytic granule secretion
Cx3cr1 Fractalkine receptor T-cell, monocyte
chemotaxis
(Continued)
TABLE 4 | Continued
Gene Protein Innate immune function
Fcer1g FCER1γ IgE receptor component
Lyn LYN Diverse immune signaling
pathways
Nrros Negative regulator of ROS TGFβ1 activation in
macrophages
Ptpn6 PTPN6 Hematopoietic cell signaling
Rab20 RAB20 Endocytosis, antibacterial
responses
Slc11a1 SLC11A1 Iron transporter,
antibacterial
Bst2 Tetherin Anti-viral
Sirpa SIRPA Dendritic cell activation
inhibitor
Tgfb1 TGFβ1 Multifunctional,
immunocyte inhibition
Axl AXL receptor tyrosine kinase TLR inhibition
Rab7b RAB7B Negative regulation of TLRs
Cluster 9 (Monocytes, Dendritic cells)
Cluster 9 cells expressed a subset of genes expressed by the macrophages of
Cluster 8: Cfp, Tgfb1, Vim, Actr3, Ccl6, Ccl9, Cd74, Coro1a, Cybb, Fcer1g,
Ly86, Nrros, Ptpn6 and Unc93b1. However, they also expressed:
Myo1f Myosin 1F Immune cell motility
Klrd1 KLRD1 MHC recognition by
cytotoxic cells
Klrk1 KIRK1 Cytotoxicity of
virus-infected cells
Slamf7 SLAMF7 NK cell activation
Lgals3 Galectin 3 Monocyte, macrophage
chemotaxis
Rnase6 RNASE6 Antibacterial
Rpl39 Ribosomal protein L39 Viral gene translation
Rps19 Ribosomal protein S19 Viral gene translation
Cluster 10 (T-cells, NK cells)
Hmgb2 HMGB2 Innate immune DNA/RNA
receptor
Txk TXK tyrosine kinase Th1 cytokine production
Coro1a Coronin 1A Lytic granule secretion
Klrd1 KLRD1 MHC recognition by
cytotoxic cells
Klrk1 KIRK1 Cytotoxicity of
virus-infected cells
Ccl5 Chemokine CCL5, RANTES T-cell chemotaxis
Rpl14a Ribosomal protein 14a Viral replication and gene
translation
Cluster 14 (ILC2s)
Coro1a Coronin 1A Lytic granule secretion
Samhd1 SAMHD1 Mediates TNF inflammatory
responses
Arg1 Arginase 1 Promotes acute type 2
inflammation
C1qbp C1q binding protein Multiple
immune/inflammatory
responses
Ccl1 Chemokine CCL1 Monocyte chemotaxis
(Continued)
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TABLE 4 | Continued
Gene Protein Innate immune function
Cluster 15 (B-cells)
Ly86 MD-1 LPS receptor component
Unc93b1 UNC93B1 Required for TLR DNA
recognition
Cd74 CD74 MHC class II antigen
processing
Ptpn6 PTPN6
Coro1a Coronin 1A Lytic granule secretion
Slamf7 SLAMF7 NK cell activation
Irf8 IFN response factor 8 Regulates IFN responses
Cluster 16 (Melanocytes)
Vim Vimentin Viral and bacterial
attachment
Mif MMIF Pro-inflammatory mediator
Gapdh GAPDH Inhibits IFN-induced gene
expression
validating lymphatic endothelial cells of Cluster 9 cells. The
documentation of capillaries and post-capillary venules in the
ME (e.g., Goldie and Hellström, 1990) makes the observation of
pericytes in Cluster 13 unremarkable. Gene expression related to
hypoxia, contractility and water permeability are consistent with
pericyte regulation of vascular tone, based on oxygen tension, and
fluid entry into the ME.
Leukocytes
Clusters 8 and 9 expressed monocyte markers, while most Cluster
8 cells also expressed macrophage genes consistent with an
M2 (alternatively activated) phenotype. Macrophages have been
documented in the normal ME (Takahashi et al., 1989; Jecker
et al., 1996), but the M2 phenotype has not previously been
appreciated. The dendritic cells and less defined monocytes
of Cluster 9 have also been noted before in the ME (Jecker
et al., 1996). The expression of genes associated with cytotoxicity
by dendritic cells indicates a killer phenotype, not recognized
previously at this site. Less differentiated monocytes of the
classical and resident phenotypes have also not previously been
differentiated in the resting ME.
Cells in Clusters 10, 14, and 15 expressed a lymphocyte marker
gene Ptprcap. Cluster 10 also expressed T-cell and NK-cell genes,
while Cluster 15 expressed genes found in B-cells. All three
of these lymphocyte types have been reported from the ME
(Takahashi et al., 1989). However, the ILC2s of Cluster 14 were
not previously reported to be present in the ME.
The number of leukocytes in the normal ME mucosa has
often been reported to be relatively low (e.g., Takahashi et al.,
1989), and lymphocytes to be especially uncommon (Jecker et al.,
1996). However, we observed a substantial number of leukocytes
(14.7%) in our normal ME cell samples. This disparity could be
caused by differential survival of cells through the tissue digestion
and cellular dispersion processes employed. However, it seems
unlikely that leukocytes would be dramatically more resistant to
these procedures than other cells. Another potential explanation
is the diversity of subtypes and the difficulty of definitively
identifying leukocytes. For example, many investigators have
used the MAC1 antibody, which labels the Itgam gene product
present in mature macrophages, to identify these cells. However,
we found that few macrophages in the normal ME expressed
this gene, since the macrophages were likely M2 cells of
incomplete maturity.
It should be noted that not all leukocytes known to be
present in the ME were found in this study. Several groups (e.g.,
Watanabe et al., 1991), including our own (Ebmeyer et al., 2005),
have documented the presence of mast cells in the normal ME
mucosa. Despite this, we were unable to identify any consistent
mast cell gene signatures in our cell samples. For example, the
entire family of seven mast cell protease (Mcpt) genes showed
no expression in any of our ME cells. Other mast cell markers
were either absent or were expressed in various cells that had
been identified as other cell types with no consistent pattern. The
reasons for this are not clear. The number of mast cells in the
ME mucosa is not high, so this could represent a sampling issue.
Alternatively, the C57BL/6 mouse used in this study may lack ME
mast cells, as compared to the guinea pig or WB/B6F1 hybrid
mice used in the above studies. However, it seems most likely that
mast cells did not survive the cell dissociation method used in this
study. The fragility of mast cells isolated from tissues has been
noted by others (Kulka and Metcalfe, 2010).
With the exception of mast cells, we were thus able to identify
all of the cell types that have been identified previously in the ME
using alternative methodologies. In addition, we added new types
not previously identified in the normal tympanic cavity. Finally,
we obtained a sufficient number of cells for each type to evaluate
their individual transcriptomes. This allowed us to achieve our
goal of documenting the differences in cell function, as well as the
expression of innate immune genes across ME cell types.
Differential Functions of ME Cell Types
Expression differences identified by clustering analysis and
screening of innate immune gene beyond those that specified
cell identity, provided clues as to the functional role of cells
in the normal ME.
Epithelial Cells
The movement of fluids across the mucosal epithelium into and
out of the ME is clearly an important aspect of ME homeostasis,
OM pathogenesis and fluid clearance during recovery from
infection. As indicated by claudin gene expression, the cells
of the epithelium are joined by tight junctions. Therefore the
expression of genes involved in fluid/solute transport across cell
membranes by all epithelial clusters is not unexpected, as is
expression of the surface liquid layer homeostasis gene Bipfa1.
Cluster 1 epithelial cells also expressed many genes consistent
with presence at the epithelial surface and with secretory
activity, including cell-surface and secreted mucins as well
as antimicrobials. Cluster 0 similarly expressed antimicrobials,
along with surfactant D and ECM-binding genes, suggesting
a possible role in basement membrane interactions and that
secretory activity is distributed across more than one epithelial
cell type. As noted above, Cluster 6 gene expression overlapped
with that of Cluster 0 and 1, suggesting an intermediate
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phenotype. The expression of genes related to tissue proliferation
by the basal epithelial cells of Cluster 2 are consistent with
them being a source of epithelial cells. However, they also
expressed beta defensin 1, further evidence that secretory
activity is distributed. Assuming that basal cells are located
below the epithelial surface, this antimicrobial may defend
against bacteria that invade the mucosa. Cluster 11 ciliated
cells expressed Aqp4 and Muc4. Altogether, epithelial cells of
the ME mucosa appear specialized for fluid transport and
secretory activity.
Stromal Cells
The expression of genes by stromal cell clusters was dominated
by those related to ECM generation and remodeling. Cluster 3
cells appear also to be specialized for the regulation of epithelial
and stromal cell growth, while Cluster 5 cells are likely involved
in bone maintenance and remodeling.
Vascular Cells
The vascular endothelial cells of Cluster 7 expressed many
genes involved in vascular permeability and fluid transport.
They therefore work in combination with epithelial cells
as the principle regulators of fluid balance in the ME.
Not surprisingly, they also expressed genes involved in the
recruitment of leukocytes and angiogenesis. Interestingly,
vascular and lymphatic endothelial cells each preferentially
expressed a different decoy cytokine receptor, which could
serve to limit inflammation. Expression of genes involved in
hypoxia responses and in regulating vascular tone is typical
of pericytes.
Leukocytes
Not surprisingly, most of the genes preferentially expressed
by leukocytes were involved in immune and inflammatory
responses. However, the M2 phenotype and expression of
negative immune regulators by the macrophages of Cluster
8 are consistent with a homeostatic and anti-inflammatory
role, rather than the pro-inflammatory phenotype of
classically activated macrophages. Gene expression by
dendritic cells and other monocytes of Cluster 9 was
similar, although somewhat fewer genes were preferentially
expressed. The lymphocyte types of Clusters 10, 14 and
15 preferentially expressed genes consistent with their
expected functions.
Innate Immune Genes and the Defense
of the ME
Infection of the ME activates an innate immune response
extremely rapidly (MacArthur et al., 2013; Hernandez et al.,
2015). This initial response is likely based largely on the repertoire
of innate immune receptor and effector genes that are expressed
by the cells of the normal ME. Disruption of many individual
innate immune genes in mice has been shown to reduce the
effectiveness of this innate response to infection, and to prolong
OM. Moreover, several studies have identified polymorphisms
in human innate immune genes that are linked to otitis media
proneness in patients (see Kurabi et al., 2016 for a recent
review). These studies underscore the importance of innate
immunity in the immediate and long-term defense of the ME,
which was our rationale for focusing on these genes in ME
cell transcriptomes.
As can be seen from Figure 5, expression of innate immune
genes is distributed across the various cell types of the
ME. Epithelial cells appear specialized for the detection and
response to pathogens, including the secretion of antibacterial
peptides. However, they also expressed genes related to leukocyte
recruitment and activation.
Stromal cells expressed several complement factors and pro-
inflammatory genes, suggesting potential involvement in active
inflammation. They also expressed many negative immune
regulators, not only of complement but also of innate immunity
in general as well as T- and NK-cells. They thus appear to serve
as inhibitory modulators of inflammation to a greater extent than
epithelial cells.
Endothelial cells and pericytes expressed several genes
involved in the activation of inflammatory pathways and T-cells,
but also several negative immune regulators.
The M2 macrophages in the ME expressed by far the most
innate immune genes, with an emphasis on pathogen detection,
leukocyte chemotaxis, complement activation, and both positive
and negative inflammatory regulation. Their phenotype is
consistent with immune homeostasis, but also readiness to act in
case of infection. Monocytes/dendritic cell gene expression was
similar to that seen in macrophages, but cytotoxic genes were
additionally expressed.
The lymphocytes of cluster 10 were primarily gamma-delta
T-cells that typically have an innate immune function, and
consequently expressed several pathogen receptors and innate
immune effectors. Cytotoxic T-cells and NK-cells were also
present in this cluster. The ILC2s of cluster 14 expressed
several genes involved in T-cell regulation and induction of
inflammation. The B-cells of cluster 15, as expected, expressed
genes related to antibody production.
In addition to individual genes, the GO: biological process
gene categories that were most regulated in macrophages
and monocytes are all subcategories of the GO category
for innate immunity. For the remaining ME cell types,
innate immunity was not among the GO categories with
the highest degree of regulation. This is not surprising,
since unlike macrophages and monocytes, the primary
functions of these cells are not innate immunity. However,
the fact that they also express many innate immune genes
underscores the importance of innate immunity in virtually
all ME cell types.
A striking feature of innate immune gene expression in
normal ME cells was the large number of negative regulators of
immunity and inflammation observed in the transcriptomes of
many different cell types, in parallel with to pro-inflammatory
genes. This pattern of expression suggests that, while the cells
of the ME are primed to respond to infection by generating
inflammation and other antimicrobial responses, these processes
are actively held in check by immune inhibitory genes to ensure
ME mucosal homeostasis. This not only must pro-inflammatory
gene products be activated by pathogens at the initiation of
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OM, anti-inflammatory genes may need to be downregulated to
allow maximally effective innate immunity to defend the ME.
Other investigators have noted the importance of endogenous
negative regulators in ameliorating OM Pathogenesis (e.g.,
Li et al., CYLD). Our results add a large number of
additional negative regulators which were distributed across
diverse ME cell types.
Limitations of the Study
Our analysis of single-cell transcriptomes is subject to a
number of methodological limitations. As noted above, the
numbers of different cell types recovered is dependent upon
the survival of cells through the enzymatic digestion and
dispersion techniques. While we were able to document an
effect of this for mast cells, the extent to which selection
bias may have influenced our other cell populations is not
clear. Fortunately, we obtained sufficient numbers of cells in
all cell populations to adequately survey gene transcription.
However, the proportions of each cell type in our samples
should not be taken to represent their relative abundance
in vivo.
Another limiting effect is related to the limited number of
genes that can be recovered from an individual cell. This means
that abundant mRNAs are more likely to be represented than
scarce transcripts. It has been argued that the detection of scarce
mRNAs is stochastic, and that combining the results of 20 or
more cells approaches the results of bulk RNASeq (Marinov
et al., 2014). However, the possibility that scarcer transcripts were
missed in a given cell population must be considered.
Other limitations reflect the nature of gene responses to
infection. It is of course certain that the expression of innate
immune and other genes by ME cells would change dramatically
upon infection, and that some of these changes would be very
rapid (MacArthur et al., 2013; Hernandez et al., 2015). Therefore,
the roles of ME cells in the initial stage of OM, and beyond,
would correspondingly change. Our data reflect only pre-existing
mRNAs that may be expressed in readiness for a pathogen
challenge. We plan to assess the results of infection on the
transcriptomes of ME cell types. This work is in progress, and
will be the basis of a future report. We felt that including
results from infected ME cells would have made this paper
unacceptably long.
CONCLUSION
The results of this study establish, for the first time, the differences
that exist between the transcriptomes of cells in the normal
ME. They identify not only previously known cell types, but
also show the presence of novel cell types and subtypes. The
genes that differentiate these cell types provide information on
their roles in ME homeostasis, and their ability to respond
immediately to infection. The results also provide a baseline
from which to assess the molecular responses of ME cells
to infection.
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